The market for prefilled syringes was estimated to be worth USD 7.22 billion in 2022 and is anticipated to grow to USD 7.91 billion in 2023. By 2030, the market is anticipated to reach USD 16.32 billion, growing at a CAGR of 10.9%. Prefilled...
The agreement was launched by AliveCor India Pvt. Ltd., the leading inventor in FDA-cleared personal electrocardiogram (ECG) technology, and Vieroots Wellness Solutions Pvt Ltd, a health-tech start-up focused to giving personalised solutions to...
Zion Pharma Limited, a Chinese biotechnology firm specialising in the creation of substances that may penetrate the brain, revealed today that Roche has purchased the worldwide rights to Zion's principal programme, ZN-A-1041. ZN-A-1041 is a Human...
Technologies are revolutionizing the way veterinarians diagnose and treat diseases in animals. Veterinary medicine embraces these technologies to provide more efficient and cost-effective medical care.
Zydus Lifesciences on Monday said it has received approval from the US health regulator to market a generic medication that is used to lower triglycerides, in the American market.The company has got the final approval from the US Food and Drug A...
Henry Ford Health, a not-for-profit healthcare organisation in the Detroit metro region, and Illumina Inc., a world leader in DNA sequencing and array-based technologies, have announced the beginning of a cooperation to examine the effects of...
On the lines of its Production Linked Incentive (PLI) scheme, government of India is mulling a Research Linked Incentive (RLI) programme to galvanize pharmaceutical research for development of biotechnology products, said Dr V G Somani
Entod Pharmaceuticals has announced that the company is all set to launch its GLO division to further expand its business. This one-of-a-kind ophthalmic subspeciality division is focused on the treatment of the eye condition glaucoma, which is a lead
Merck, known as MSD outside the United States and Canada, and Imago BioSciences, Inc. (Imago) announced that the companies have entered into a definitive agreement under which Merck, through a subsidiary, will acquire Imago for $36.00 per share in...
The global pharma market is expected to reach USD 1.5 trillion by next year. The industry is also expected to have a compound annual growth rate between 3 and 6 percent in the next five years. The global specialty pharmaceuticals market size is al...
, CDSCO.jpg)
